Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026)

Maze Therapeutics' (MAZE) quarterly Asset Utilization Ratio came in at 0.05 in Q1 2026, up 111.65% quarter-over-quarter from 0.42 in Q3 2025.

Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Maze Therapeutics has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.05 for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	0.55
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	0.60
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	1,422.00
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	0.47
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Maze Therapeutics	1.31 Bn	1.31 Bn	18.21 Mn	0.05

Download Data